Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             120 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Anti-growth factor therapy for lung cancer Bunn, P.A.
 1997
 18 S2 p. 10-11
2 p.
 artikel
2 A randomised multicentre trial of CHART vs conventional radiotherapy in non-small cell lung cancer Saunders, Michele I.
 1997
 18 S2 p. 28-29
2 p.
 artikel
3 A randomized trial of cisplatin plus paclitaxel versus cisplatin plus teniposide in advanced non-small cell lung cancer Giaccone, Giuseppe
 1997
 18 S2 p. 145-
1 p.
 artikel
4 Author index 1997
 18 S2 p. 161-162
2 p.
 artikel
5 Biology of MRP in drug resistance of lung cancer Cole, S.P.C.
 1997
 18 S2 p. 102-103
2 p.
 artikel
6 Brain metastases Patchell, Roy A.
 1997
 18 S2 p. 109-110
2 p.
 artikel
7 Brain metastases in lung cancer — A review Gregor, Anna
 1997
 18 S2 p. 106-
1 p.
 artikel
8 Camptothecins Fujioka, Masahiro
 1997
 18 S2 p. 57-
1 p.
 artikel
9 Cancer susceptibility genes and molecular epidemiology Haugen, Aage
 1997
 18 S2 p. 71-72
2 p.
 artikel
10 Carboplatin in the treatment of small cell lung cancer (SCLC) Ettinger, David S.
 1997
 18 S2 p. 132-
1 p.
 artikel
11 Cell surface antigens as therapeutic targets Stahel, R.
 1997
 18 S2 p. 8-
1 p.
 artikel
12 Chemoradiotherapy for stage III non-small cell lung cancer Vokes, Everett E.
 1997
 18 S2 p. 112-
1 p.
 artikel
13 Chemotherapy benefit and cost-effectiveness of treatment for advanced lung cancer Evans, William K.
 1997
 18 S2 p. 68-69
2 p.
 artikel
14 Chemotherapy for symptom control in advanced NSCLC Thatcher, Nicholas
 1997
 18 S2 p. 116-
1 p.
 artikel
15 Chemotherapy of advanced stage non-SCLC-Impact on quality of life and symptom control Smith, Ian E.
 1997
 18 S2 p. 67-
1 p.
 artikel
16 Classification of neuroendocrine tumors of the lung Travis, William D.
 1997
 18 S2 p. 43-44
2 p.
 artikel
17 Combination chemotherapy with gemcitabine in non-small-cell lung cancer Crinò, Lucio
 1997
 18 S2 p. 115-
1 p.
 artikel
18 Combined modality therapy for limited small-cell lung cancer Turrisi III, Andrew T.
 1997
 18 S2 p. 127-
1 p.
 artikel
19 Combined modality therapy for lung cancer Sause, Willam T.
 1997
 18 S2 p. 77-78
2 p.
 artikel
20 Combined modality therapy in the management of stage III non-small cell lung cancer Curran Jr., Walter J.
 1997
 18 S2 p. 144-
1 p.
 artikel
21 Combined modality therapy with radiation in NSCLC Vokes, Everett E.
 1997
 18 S2 p. 139-140
2 p.
 artikel
22 Concurrent weekly paclitaxel and radiation therapy for locally advanced non-small cell lung cancer Choy, H.
 1997
 18 S2 p. 152-
1 p.
 artikel
23 Controversies in staging non-small cell lung cancer Ginsberg, Robert J.
 1997
 18 S2 p. 142-
1 p.
 artikel
24 CPT-11 in the treatment of small-cell lung cancer Furuse, Kiyoyuki
 1997
 18 S2 p. 25-
1 p.
 artikel
25 Current and future projections in mesothelioma mortality Musk, A.William
 1997
 18 S2 p. 92-
1 p.
 artikel
26 Current status of prophylactic cranial irradiation in small cell lung cancer Arriagada, Rodrigo
 1997
 18 S2 p. 107-
1 p.
 artikel
27 Current treatment of advanced small cell lung cancer Ihde, Daniel C.
 1997
 18 S2 p. 120-
1 p.
 artikel
28 Development of topoisomerase I inhibitors in Japan Fukuoka, Masahiro
 1997
 18 S2 p. 123-
1 p.
 artikel
29 Docetaxel (DOC) for non-small cell lung cancer (NSCLC) Fossella, Frank V.
 1997
 18 S2 p. 62-63
2 p.
 artikel
30 Docetaxel in small cell lung cancer Smyth, John F.
 1997
 18 S2 p. 27-
1 p.
 artikel
31 Docetaxel (Taxotere®) in the management of advanced non-small cell lung cancer (NSCLC) Miller, Vincent A.
 1997
 18 S2 p. 136-
1 p.
 artikel
32 Do new chemotherapeutic agents improve patient outcomes in NSCLC Rigas, James R.
 1997
 18 S2 p. 135-
1 p.
 artikel
33 Dose intensity in small-cell lung cancer (SCLC) Thatcher, N.
 1997
 18 S2 p. 105-
1 p.
 artikel
34 Drug resistance in lung cancer: Topoisomerases as determinants of chemosensitivity Saijo, Nagahiro
 1997
 18 S2 p. 104-
1 p.
 artikel
35 “Dysregulated” overexpression of hnRNP A2 B1 may indicate lung epithelial transformation; in exfoliated sputum epithelial cells, a similar pattern of hnRNP overexpression may improve detection of preclinical lung cancer Tockman, M.S.
 1997
 18 S2 p. 41-
1 p.
 artikel
36 Early high-dose chemotherapy and peripheral blood progenitor cell transplantation in limited-disease small-cell lung cancer. Results of a single center phase II study Brugger, W.
 1997
 18 S2 p. 160-
1 p.
 artikel
37 Early molecular genetic events in the pathogenesis of lung cancer Rabbitts, Pamela
 1997
 18 S2 p. 75-
1 p.
 artikel
38 Epidemiology of lung cancer: Past, present and future Boyle, Peter
 1997
 18 S2 p. 119-
1 p.
 artikel
39 Euroscan van Zandwijk, N.
 1997
 18 S2 p. 86-87
2 p.
 artikel
40 Evidence for the impact of quality of life Hopwood, Penelope
 1997
 18 S2 p. 66-
1 p.
 artikel
41 Future directions in the management of non-small cell lung cancer: A continuing perspective Ruckdeschel, J.
 1997
 18 S2 p. 151-
1 p.
 artikel
42 Future directions in the treatment of small cell lung cancer Comis, Robert
 1997
 18 S2 p. 133-
1 p.
 artikel
43 Gene replacement for lung cancer Roth, J.A.
 1997
 18 S2 p. 76-
1 p.
 artikel
44 Gene therapy or therapy with intratumoral cytokines by infusion in mesothelioma patients Davidson, A.
 1997
 18 S2 p. 94-95
2 p.
 artikel
45 Gene therapy strategies for lung cancer Roth, J.A.
 1997
 18 S2 p. 141-
1 p.
 artikel
46 High dose rate brachytherapy in endobronchial tumours Burt, Paul A.
 1997
 18 S2 p. 35-
1 p.
 artikel
47 High-resolution computed tomography of bronchioloalveolar cell carcinoma Eguchi, Kenji
 1997
 18 S2 p. 16-
1 p.
 artikel
48 Ifosfamide and gemcitabine in advanced non-small cell lung cancer (NSCLC) Gatzemeier, O.
 1997
 18 S2 p. 156-
1 p.
 artikel
49 Ifosfamide and taxotere in non-small cell lung cancer Drings, P.
 1997
 18 S2 p. 159-
1 p.
 artikel
50 Ifosfamide and vinorelbine in advanced non-small cell lung cancer Masters, Gregory A.
 1997
 18 S2 p. 155-
1 p.
 artikel
51 Ifosfamide-based three-drug combinations in non-small cell lung cancer Vokes, Everett E.
 1997
 18 S2 p. 157-
1 p.
 artikel
52 Immunoscintigraphy in the diagnosis and staging of lung cancer Buccheri, Gianfranco
 1997
 18 S2 p. 99-
1 p.
 artikel
53 Induction chemotherapy for early stage non-SCLC Tonato, M.
 1997
 18 S2 p. 81-
1 p.
 artikel
54 Induction of p53 ras specific cellular immunity in patients with common solid tumors Gabrilovich, Dmitry
 1997
 18 S2 p. 90-91
2 p.
 artikel
55 Insulin-like growth factors in lung cancer Havemann, Klaus
 1997
 18 S2 p. 9-
1 p.
 artikel
56 Integration of chemotherapy and radiation therapy for small cell lung cancer Arriagada, Rodrigo
 1997
 18 S2 p. 82-83
2 p.
 artikel
57 Intermediate end point markers in chemoprevention trials of lung cancer Lee, Jin S.
 1997
 18 S2 p. 88-89
2 p.
 artikel
58 Is there a role for induction radiotherapy in stage IIIA NSCLC? Payne, David G.
 1997
 18 S2 p. 53-54
2 p.
 artikel
59 Laser-assisted bronchoscopy in the early detection and treatment of lung cancer Lam, Stephen
 1997
 18 S2 p. 42-
1 p.
 artikel
60 Major lung resection by VATS Naruke, Isuguo
 1997
 18 S2 p. 20-
1 p.
 artikel
61 Manipulation of cigarette production to cause and enhance addiction Douglas, Clifford E.
 1997
 18 S2 p. 5-6
2 p.
 artikel
62 Mechanistic and pharmacokinetic considerations in the use of topotecan alone and in combination Johnson, Randall K.
 1997
 18 S2 p. 122-
1 p.
 artikel
63 Molecular biology of neuroendocrine lung tumors Brambilla, E.
 1997
 18 S2 p. 46-
1 p.
 artikel
64 Molecular pathogenesis of lung cancer and the potential translational application of these results to the clinic Minna, John D.
 1997
 18 S2 p. 73-74
2 p.
 artikel
65 Molecular-pathological assessment of individuals with a high risk of developing lung cancer Field, John K.
 1997
 18 S2 p. 39-
1 p.
 artikel
66 MRI and PET in lung cancer: Help or hindrance? Lynch, David A.
 1997
 18 S2 p. 98-
1 p.
 artikel
67 Neuropeptides, signal transduction and small cell lung cancer Rozengurt, Enrique
 1997
 18 S2 p. 7-
1 p.
 artikel
68 New chemotherapy combinations with docetaxel (Taxotere®), in the treatment of patients with non-small cell lung cancer Donnellan, P.P.
 1997
 18 S2 p. 137-
1 p.
 artikel
69 Non-small cell lung cancer: Improved chemotherapy Einhorn, Lawrence H.
 1997
 18 S2 p. 111-
1 p.
 artikel
70 Overcoming drug resistance in lung cancer Saijo, Nagahiro
 1997
 18 S2 p. 150-
1 p.
 artikel
71 Overview of lung cancer screening and early cancer detection Mulshine, James L.
 1997
 18 S2 p. 37-38
2 p.
 artikel
72 Paclitaxel and ifosfamide combinations for non-small cell lung cancer Shepherd, Frances A.
 1997
 18 S2 p. 153-
1 p.
 artikel
73 Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung cancer Hainsworth, John D.
 1997
 18 S2 p. 131-
1 p.
 artikel
74 Paclitaxel — Carboplatin regimen in advanced and metastatic non-small cell lung cancer Belani, Chandra P.
 1997
 18 S2 p. 149-
1 p.
 artikel
75 Paclitaxel combination chemotherapy in non-small cell lung cancer Johnson, David H.
 1997
 18 S2 p. 55-56
2 p.
 artikel
76 Paclitaxel for small cell lung cancer (SCLC) Raghavan, Derek
 1997
 18 S2 p. 23-
1 p.
 artikel
77 Paclitaxel plus carboplatin therapy in advanced non-small cell lung cancer: A multicenter study of the Minnie Pearl Cancer Research Network Greco, E.Anthony
 1997
 18 S2 p. 148-
1 p.
 artikel
78 Papillary adenocarcinoma vs bronchioloalveolar carcinoma: (1) Pathology: Genetic changes and outcome Noguchi, M.
 1997
 18 S2 p. 15-
1 p.
 artikel
79 Phase I study on docetaxel and ifosfamide in patients with advanced solid tumors Pronk, L.C.
 1997
 18 S2 p. 158-
1 p.
 artikel
80 Predicting pulmonary toxicity of radiation Theuws, J.C.M.
 1997
 18 S2 p. 33-34
2 p.
 artikel
81 Pre-operative and post-operative radiation therapy in non-SCLC Van Houtte, Paul
 1997
 18 S2 p. 51-52
2 p.
 artikel
82 Primary prevention of lung cancer in the United States Ihde, Daniel C.
 1997
 18 S2 p. 84-85
2 p.
 artikel
83 Prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC) — When is it indicated? Gregor, Anna
 1997
 18 S2 p. 128-
1 p.
 artikel
84 Proposal for WHO histological typing of lung tumors: Adenocarcinoma and related tumors Aisner, Seena
 1997
 18 S2 p. 14-
1 p.
 artikel
85 Radiotherapy [RT] for non-small cell lung cancer [NSCLC]: Defining the target volumes Ball, D.
 1997
 18 S2 p. 31-32
2 p.
 artikel
86 Recent advances in the treatment of non-small cell lung cancer with chemotherapy: The ECOG experience Johnson, David H.
 1997
 18 S2 p. 146-147
2 p.
 artikel
87 Retinoids and their nuclear receptors in the development, prevention, and treatment of upper airways epithelial cancers Lotan, Reuben
 1997
 18 S2 p. 12-13
2 p.
 artikel
88 Single agent gemcitabine activity in non-small cell lung cancer Shepherd, Frances A.
 1997
 18 S2 p. 114-
1 p.
 artikel
89 Small cell lung cancer; What is standard? Postmus, Pieter E.
 1997
 18 S2 p. 129-130
2 p.
 artikel
90 Subclassification of small cell lung cancer (SCLC) and significance of non-SCLC with neuroendocrine features Hirsch, Fred R.
 1997
 18 S2 p. 47-
1 p.
 artikel
91 Surgical resection for non-small cell lung cancer: The impact of chemotherapy Ginsberg, Robert J.
 1997
 18 S2 p. 79-80
2 p.
 artikel
92 Surgical results for mesothelioma: Implications for a new staging system Rusch, Valerie W.
 1997
 18 S2 p. 93-
1 p.
 artikel
93 Surgical techniques for palliative management of lung cancer Pastorino, Ugo
 1997
 18 S2 p. 64-65
2 p.
 artikel
94 Telomerase dysregulation during the multistage pathogenesis of lung cancer Gazdar, Adi F.
 1997
 18 S2 p. 40-
1 p.
 artikel
95 The benefits of combination chemotherapy for stage III and IV non-small cell lung cancer Kris, Mark G.
 1997
 18 S2 p. 134-
1 p.
 artikel
96 The biological basis of drug resistance in lung cancer Twentyman, Peter R.
 1997
 18 S2 p. 100-101
2 p.
 artikel
97 The clinical significance of drug resistance in lung cancer Giaccone, Giuseppe
 1997
 18 S2 p. 121-
1 p.
 artikel
98 The effect of gemcitabine in non-small cell lung cancer Hansen, Heine H.
 1997
 18 S2 p. 60-61
2 p.
 artikel
99 The emerging role of topotecan in the treatment of SCLC Hansen, Heine H.
 1997
 18 S2 p. 124-
1 p.
 artikel
100 The food and drug administration's regulation of tobacco products Wilkenfeld, Judith D.
 1997
 18 S2 p. 3-
1 p.
 artikel
101 The importance of local control with irradiation in lung cancer Abratt, Raymond P.
 1997
 18 S2 p. 48-49
2 p.
 artikel
102 The importance of lymph node dissection in the local control of non-small cell lung cancer (SCLC) Tsuchiya, Ryosuke
 1997
 18 S2 p. 50-
1 p.
 artikel
103 The integration of newer agents in neo-adjuvant therapy Rosell, Rafael
 1997
 18 S2 p. 138-
1 p.
 artikel
104 The politics of tobacco Gray, Nigel
 1997
 18 S2 p. 4-
1 p.
 artikel
105 The role of and significance of autocrine growth factors and neuroendocrine markers in the development of small cell lung cancer Johnson, Bruce E.
 1997
 18 S2 p. 125-126
2 p.
 artikel
106 The role of gemcitabine in the treatment of small cell lung cancer Shepherd, Frances A.
 1997
 18 S2 p. 24-
1 p.
 artikel
107 The role of prognostic factors and oncogenes in the detection and management of NSCLC van Zandwijk, N.
 1997
 18 S2 p. 143-
1 p.
 artikel
108 The role of thoracoscopy in the diagnosis and staging of lung cancer Putnam Jr., Joe B.
 1997
 18 S2 p. 21-
1 p.
 artikel
109 Three-dimensional conformal radiotherapy Armstrong, John G.
 1997
 18 S2 p. 30-
1 p.
 artikel
110 Topotecan in small cell lung cancer Schiller, Joan H.
 1997
 18 S2 p. 26-
1 p.
 artikel
111 Treatment of brain metastases from small cell lung cancer. Is there a difference with other metastatic sites? Postmus, Pieter E.
 1997
 18 S2 p. 108-
1 p.
 artikel
112 Treatment of NSCLC with chemotherapy is controversial because of low response and high cost Evans, William K.
 1997
 18 S2 p. 117-118
2 p.
 artikel
113 Tumor suppressor genes: At the crossroads of molecular carcinogenesis, molecular epidemiology and cancer therapy Harris, Curtis C.
 1997
 18 S2 p. 113-
1 p.
 artikel
114 Uncommon adenocarcinomas Colby, Thomas V.
 1997
 18 S2 p. 17-
1 p.
 artikel
115 Video-assisted thoracic surgery in the management of lung cancer Goldstraw, Peter
 1997
 18 S2 p. 18-19
2 p.
 artikel
116 Video-assisted thoracoscopic lobectomy and pneumonectomy for lung cancer Roviaro, Giancarlo
 1997
 18 S2 p. 22-
1 p.
 artikel
117 Vinorelbine (Navelbine®) in non-small cell carcinoma Le Chevalier, Thierry
 1997
 18 S2 p. 58-59
2 p.
 artikel
118 VP-16 plus ifosfamide plus cisplatin (VIP) in small cell lung cancer Sandler, Alan
 1997
 18 S2 p. 154-
1 p.
 artikel
119 What chemotherapy has to offer in the treatment of mesothelioma Van Meerbeeck, Jan P.
 1997
 18 S2 p. 96-97
2 p.
 artikel
120 Why are bronchopulmonary carcinoid tumours unique? Hasleton, P.S.
 1997
 18 S2 p. 45-
1 p.
 artikel
                             120 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland